Thrombus News and Research

RSS

A blood clot or thrombus, is the final product of the blood coagulation step in hemostasis. It is achieved via the aggregation of platelets that form a platelet plug, and the activation of the humoral coagulation system (i.e. clotting factors).

New therapy for blood clots in the legs appears to be safe and effective

A novel treatment for blood clots in the legs appears to be safe and effective, according to a pilot study published in the February issue of Radiology.

30 Jan 2008

Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma

Portal venous tumor thrombus (PVTT) is a crucial factor that can worsen the prognosis of patients with hepatocellular carcinoma (HCC).

18 Oct 2007

Trial of repeated antibiotic therapy for Lyme diseases

Findings from the first placebo-controlled study of chronic cognitive impairment after treated Lyme disease (also known as chronic Lyme encephalopathy) demonstrate that patients report moderate cognitive impairment, physical dysfunction comparable to patients with congestive heart failure, and fatigue comparable to patients with multiple sclerosis.

10 Oct 2007

Air pollutants and blood clotting link

Air pollution is caused by any particulate matter, chemical, or biological agent that changes the natural characteristics of the atmosphere.

21 Sep 2007

OPTIMIST: The Outcome of PCI for stent-ThrombosIs MultIcentre STudy

Stent thrombosis is a recognized complication occurring in 1-2% of patients with coronary artery disease treated by percutaneous coronary intervention (PCI) with stent implantation. Its occurrence is expected to increase with the number of stent implantation procedures done worldwide. Moreover, stent thrombosis is a hot topic in the cardiology community.

3 Sep 2007

DES: friend or foe?

The current FDA approved stents (CYPHER and TAXUS) have been associated with late stent thrombosis (LST) (>30days following implantation) however, the mechanisms predictive of LST are poorly understood. Pathologic studies are one of the best methods for detailed analysis of morphologic changes that occur after placement of Drug Eluting Stents to determine the causes of LST.

3 Sep 2007

Four hours in ecomony class doubles the risk for deep vein thrombosis

According to the World Health Organization (WHO) the chances of developing deep vein thrombosis ( DVT) double after traveling for four hours or more; this says WHO equates to one in 6,000 long-haul passengers at risk of potentially dangerous blood clots.

2 Jul 2007

New option for soft-tissue imaging in interventional radiology procedures

Soft-tissue cross-sectional imaging acquired on a flat panel C-arm fluoroscopic unit located in the interventional radiology area is feasible and useful for interventional radiology procedures, avoiding the necessity of sending patients out to a CT scanner, according to a new study by researchers from the Baptist Cardiac & Vascular Institute in Miami, FL.

8 May 2007

Embolic protection and platelet inhibition during renal artery stenting

High blood pressure is the most common chronic medical condition in the United States, and the most common identifiable cause is narrowing of a kidney artery, called renal artery stenosis.

3 Apr 2007

Venacavoscopy assisted inferior Vena cava thrombus resection for T3b/c renal cell carcinoma

Resection of intrahepatic and suprahepatic inferior vena cava (IVC) thrombi associated with renal cell carcinoma (RCC) can be surgically demanding procedures that can involve multidisciplinary surgical teams.

5 Sep 2006

A tissue marker of poor prognosis in clear cell renal cell carcinoma

The search for molecular markers that further advance our knowledge of the biology of renal cell carcinoma (RCC) and assist in evaluating the diagnosis and prognosis of patients remains the subject of intense investigation.

20 Aug 2006

German scientists synthesize new compound that reduces stroke damage

A group of German scientists has synthesized a new compound that dramatically decreases the damage to neurons in rats demonstrating stroke symptoms.

16 May 2006

Sildenafil improves blood flow after heart attack in an animal model

Dogs treated with sildenafil, a drug most commonly used to treat erectile dysfunction, had better blood flow in coronary arteries than control animals, following an induced artery obstruction and treatment that modeled a heart attack and standard medical care given to people

13 Apr 2006

Chronic stress induces rapid occlusion of angioplasty

Chronic stress can induce rapid blocking of arteries after a balloon angioplasty procedure, according to research performed in animal studies at Georgetown University Medical Center. Blocked coronary arteries after angioplasty affect 41 percent of patients who undergo the procedure and can lead to death.

28 Nov 2005

Leeches, useful tools in the treatment of cardiovascular diseases

The leech has recently confirmed its biomedical interest for scientists by showing that it contains an extensive list of new potential molecules that may become useful tools in the treatment of cardiovascular diseases.

24 Oct 2005

Doctors may in future be able to prevent many cases of deep-vein thrombosis

Doctors may in future be able to prevent many cases of deep-vein thrombosis, commonly referred to as DVT, a disease of the circulation that causes potentially fatal blood clots. It occurs most often in people who have not been able to exercise normally.

9 Mar 2005

Heart bypass gets new source for replacement blood vessels

The search for a stable, renewable source of blood vessels, especially for potential use in heart bypass surgery, has reached a milestone at the State University of New York at Buffalo.

11 Nov 2004

Research may lead to elimination of surface-induced thrombus formation

A University of Missouri-Rolla researcher’s investigation into how proteins adhere to surfaces may lead the elimination of surface-induced thrombus formation, a phenomenon known to cause blood clots in artificial arteries, valves and veins.

26 May 2004

Genetic flaw that may put some people at far greater risk of heart attacks

One of the significant players in this event is the molecule cytokine lymphotoxin-alpha (LTA), which helps to regulate inflammation, a result of the emergency call upon the body's immune system.

6 May 2004

New treatment for heart attacks

A team led by scientists at The Scripps Research Institute has developed a potential new treatment for heart attacks. The therapy inhibits fluid leakage from cardiac blood vessels following a heart attack and thereby significantly prevents long-term heart damage and improves survival.

22 Mar 2004